Gentury

Gentury Biomedical, LLC is a US-based, biology-focused contract research organization specializing in preclinical drug discovery and development. The company supports pharmaceutical and biotechnology clients with services spanning hit identification, hit-to-lead research, lead optimization, and preclinical studies. Its capabilities include biological assay development and high-throughput screening in 96- and 384-well formats, compound profiling, and genetic biomarker analysis.

Gentury also provides DMPK and bioanalytical services, including pharmacokinetic and pharmacodynamic studies, ADME, solubility, stability, and Caco-2 testing. Its in vivo pharmacology and disease-model work covers areas such as central nervous system disorders, oncology, metabolic diseases, and inflammation, alongside in vitro and in vivo safety and toxicology services. Additional offerings include natural product-based lead discovery, herbal extracts, therapeutic-focused compound libraries, custom antibody services, and protein and antibody arrays for studying human proteomes.

Gentury describes its approach as a customized, integrated service package, bringing together expertise and technology platforms from early discovery through preclinical development. The company reports collaborations with major pharmaceutical firms as well as mid-sized pharma and biotech organizations